Statistics
Publications
2
Citations
47
H-Index
2
Active since
2024
Affiliations
Samuel Gebhardt is an author at Roche Pharma AG (Germany) specializing in t cell-mediated tumor killing, immunotherapy, and bispecific antibody therapy.
Publications per year
2024–2025
2
2
Preclinical advances in glofitamab combinations: a new frontier for non-Hodgkin lymphoma
Johannes Sam, Gabrielle Leclercq-Cohen, Samuel Gebhardt et al. · Blood · 2025 · 10 citations · Full text
Medicine, Oncology, Pharmacology +17
1–2 of 2